TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
OCUL

Ocular Therapeutix Inc

Healthcare · Biotechnology

6.20$ -1.1% vs. previous close Closing price · As of: Nov 13, 2026

Investor relations

Report Dates

Investor relations overview for Ocular Therapeutix Inc (OCUL): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/09/2026.

Next report 11/09/2026
Last report 08/03/2026
Earnings surprise by quarter (%)
Q4 23 · -16.7 % 23 Q1 24 · -33.3 % 24 Q2 24 · -23.8 % 24 Q3 24 · -4.8 % 24 Q4 24 · -31.8 % 24 Q1 25 · -32.1 % 25 Q2 25 · -11.4 % 25 Q3 25 · -8.6 % 25 Q4 25 · 14.7 % 25 Q1 26 · -29.0 % 26 Q2 26 · 12.5 % 26

EPS estimate beaten

Full history 16 of 48 quarters (33%)
Last 16 quarters 5 of 16 quarters (31%)

Earnings Call Transcripts

Search all transcripts →

  • 11/09/2026 Earnings Call Q3 2026 Open →

News on This Stock

  • 11/09/2026 OCULAR THERAPEUTIX, INC (OCUL): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers · sec.gov Open ↗
  • 11/09/2026 OCULAR THERAPEUTIX, INC (OCUL): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 10/16/2026 OCULAR THERAPEUTIX, INC (OCUL): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers · sec.gov Open ↗
  • 08/03/2026 OCULAR THERAPEUTIX, INC (OCUL): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?